RBC Capital Positive on BioMarin Pharma (BMRN) Following Talazoparib Sale (MDVN)

Go back to RBC Capital Positive on BioMarin Pharma (BMRN) Following Talazoparib Sale (MDVN)

Form 8-K BIOMARIN PHARMACEUTICAL For: Aug 21

August 24, 2015 7:12 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

... More